Sonnet BioTherapeutics I...

NASDAQ: SONN · Real-Time Price · USD
1.41
-0.02 (-1.40%)
At close: May 01, 2025, 3:59 PM
1.40
-0.36%
After-hours: May 01, 2025, 05:57 PM EDT

Sonnet BioTherapeutics Revenue

Sonnet BioTherapeutics reported an annual revenue of $18.63K, reflecting a -87.4% growth. For the quarter ending December 31, 2024, Sonnet BioTherapeutics generated $1M in revenue.
Revenue (ttm)
$18.63K
Revenue Growth
-87.4%
Price / Sales Ratio
235.35
Revenue / Employee
$1.43K
Employees
13
Market Cap
4.31M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.